NALTREXONE HYDROCHLORIDE TABLETS USP 50 MG
NALTREXONE HYDROCHLORIDE : 50 MG · DIN 02451883 · STERINOVA INC.
Health Canada status: MARKETED
What is NALTREXONE HYDROCHLORIDE TABLETS USP?
NALTREXONE HYDROCHLORIDE TABLETS USP 50 MG contains NALTREXONE HYDROCHLORIDE : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 02451883, held by STERINOVA INC., supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 30-May-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is NALTREXONE HYDROCHLORIDE TABLETS USP used for?
Naltrexone Hydrochloride Tablets USP (naltrexone hydrochloride) is indicated to provide blockade of the pharmacologic effects of exogenously administered opioids as an adjunct to the maintenance of the opioid-free state in detoxified, formerly opioid-dependent individuals. Naltrexone Hydrochloride Tablets USP is indicated in the treatment of alcohol dependence, as a component of a comprehensive psychotherapeutic or psychological alcoholism counselling program to support abstinence, and reduce the risk of relapse.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02451883 |
|---|---|
| Brand name | NALTREXONE HYDROCHLORIDE TABLETS USP |
| Generic / active ingredient | NALTREXONE HYDROCHLORIDE : 50 MG |
| Manufacturer | STERINOVA INC. |
| Strength | 50 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N07BB04 NALTREXONE |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 30-May-2017 |
How is it stored and handled?
null
How is it supplied?
null
What can be used instead?
Other Canadian products sharing ATC code N07BB04 NALTREXONE. 3 of 5 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-NALTREXONE | 50 MG | TABLET | APOTEX INC | MARKETED | DIN 02444275 |
| REVIA | 50 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 02213826 |
| REVIA - TAB 50MG | 50 MG | TABLET | DUPONT MERCK PHARMA INC. | CANCELLED POST MARKET | DIN 02158655 |
| RPC-NALTREXONE | 50 MG | TABLET | RUSAN PHARMA CANADA INC. | APPROVED | DIN 02558343 |
Who else supplies NALTREXONE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. NALTREXONE appears in 11 registered pack listings across 5 markets, published on 5 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.